ALPS Advisors’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $298K | Sell |
27,007
-9,072
| -25% | -$100K | ﹤0.01% | 936 |
|
|
2025
Q1 | $322K | Sell |
36,079
-3,680
| -9% | -$32.9K | ﹤0.01% | 880 |
|
|
2024
Q4 | $374K | Buy |
39,759
+2,323
| +6% | +$21.9K | ﹤0.01% | 737 |
|
|
2024
Q3 | $302K | Sell |
37,436
-508
| -1% | -$4.09K | ﹤0.01% | 956 |
|
|
2024
Q2 | $322K | Buy |
+37,944
| New | +$322K | ﹤0.01% | 814 |
|
|
2018
Q4 | – | Sell |
-97,513
| Closed | -$3.19M | – | 937 |
|
|
2018
Q3 | $3.19M | Buy |
97,513
+17,906
| +22% | +$585K | 0.02% | 198 |
|
|
2018
Q2 | $1.81M | Buy |
79,607
+7,043
| +10% | +$160K | 0.01% | 239 |
|
|
2018
Q1 | $1.76M | Buy |
72,564
+12,613
| +21% | +$306K | 0.01% | 221 |
|
|
2017
Q4 | $1.67M | Buy |
59,951
+6,938
| +13% | +$193K | 0.01% | 206 |
|
|
2017
Q3 | $1.82M | Buy |
53,013
+4,944
| +10% | +$169K | 0.01% | 196 |
|
|
2017
Q2 | $1.92M | Buy |
+48,069
| New | +$1.92M | 0.01% | 186 |
|
|
2015
Q2 | – | Sell |
-15,967
| Closed | -$277K | – | 689 |
|
|
2015
Q1 | $277K | Buy |
+15,967
| New | +$277K | ﹤0.01% | 627 |
|